Omnicell (NASDAQ:OMCL – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.550-0.620 for the period, compared to the consensus estimate of 0.470. The company issued revenue guidance of $295.0 million-$305.0 million, compared to the consensus revenue estimate of $287.9 million. Omnicell also updated its FY 2024 guidance to 1.650-1.720 EPS.
Omnicell Stock Performance
Shares of Omnicell stock traded up $0.03 on Friday, reaching $48.67. 683,792 shares of the company were exchanged, compared to its average volume of 528,146. Omnicell has a 1-year low of $25.12 and a 1-year high of $55.74. The company has a quick ratio of 2.22, a current ratio of 1.05 and a debt-to-equity ratio of 0.47. The company’s 50-day moving average is $43.26 and its two-hundred day moving average is $35.17.
Omnicell (NASDAQ:OMCL – Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.14 by $0.37. The firm had revenue of $276.80 million during the quarter, compared to analysts’ expectations of $254.41 million. Omnicell had a negative net margin of 1.66% and a positive return on equity of 2.55%. Omnicell’s quarterly revenue was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.29 EPS. On average, equities research analysts forecast that Omnicell will post 0.64 earnings per share for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Omnicell
Omnicell Company Profile
Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
Read More
- Five stocks we like better than Omnicell
- Business Services Stocks Investing
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- The Most Important Warren Buffett Stock for Investors: His Own
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.